bf/NASDAQ:XERS_icon.jpeg

NASDAQ:XERS

Xeris Biopharma Holdings, Inc.

  • Stock

USD

Last Close

7.71

06/11 22:33

Market Cap

319.49M

Beta: -

Volume Today

1.82M

Avg: 1.25M

PE Ratio

−4.97

PFCF: −4.75

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.03
-
0.03
7.86%
0.02
40.61%
0.02
21.61%
0.13
407.06%
0.16
28.66%
0.32
96.40%
0.48
50.30%
cash conversion cycle
-59.96K
-
-180.03K
200.24%
-7.10K
96.06%
-24.17
99.66%
329.39
1,462.61%
380.46
15.51%
426.67
12.15%
339.38
20.46%
cash per share
14.87
-
19.38
30.30%
9.35
51.75%
2.89
69.05%
3.14
8.43%
1.30
58.69%
0.90
30.62%
0.53
41.48%
company equity multiplier
-1.05
-
-0.78
25.90%
1.59
304.57%
7.55
374.30%
4.71
37.56%
3.20
32.20%
7.62
138.56%
-50.25
759.08%
days of inventory outstanding
495.47
-
326.85
34.03%
496.55
51.92%
398.88
19.67%
358.99
10.00%
days of payables outstanding
60.00K
-
180.31K
200.53%
7.53K
95.83%
1.28K
83.05%
121.97
90.44%
244.58
100.53%
74.28
69.63%
106.90
43.92%
days of sales outstanding
34.29
-
281.26
720.16%
424.82
51.04%
756.15
77.99%
124.50
83.53%
128.48
3.20%
102.07
20.56%
87.28
14.49%
dividend yield
0.33
-
0.46
38.28%
ebit per revenue
-12.31
-
-17.11
39.05%
-24.07
40.67%
-44.96
86.75%
-4.15
90.78%
-2.32
43.98%
-0.74
67.99%
-0.27
63.87%
ebt per ebit
1.00
-
1.00
0.12%
1.01
1.53%
1.03
1.73%
1.09
6.05%
1.07
2.42%
1.17
10.03%
1.44
23.05%
effective tax rate
0.00
-
-0.00
116.58%
-0.03
79,853.71%
0.00
112.07%
0.00
66.83%
0.01
-
0.02
32.71%
enterprise value multiple
-0.88
-
-0.07
92.17%
-3.31
4,675.02%
-1.86
43.65%
-3.22
72.59%
-2.20
31.55%
-3.61
63.84%
-15.73
336.05%
fixed asset turnover
3.45
-
1.97
42.69%
1.21
38.63%
0.35
71.40%
3.01
766.97%
7.48
149.01%
3.89
48.08%
5.62
44.60%
free cash flow per share
-7.43
-
-11.69
57.32%
-4.80
58.96%
-4.04
15.81%
-1.90
53.01%
-1.22
35.58%
-0.76
37.64%
-0.37
51.92%
gross profit margin
0.99
-
1.00
0.49%
0.98
1.45%
0.41
58.18%
0.54
30.67%
0.73
36.16%
0.79
8.65%
0.76
4.48%
interest coverage
-6.62K
-
-13.31K
101.26%
-23.32
99.82%
-17.09
26.73%
-7.84
54.13%
-16.04
104.64%
-5.35
66.66%
-1.65
69.07%
inventory turnover
0.74
-
1.12
51.59%
0.74
34.18%
0.92
24.49%
1.02
11.11%
long term debt to capitalization
0.30
-
0.80
169.68%
0.72
10.11%
0.48
33.31%
0.81
69.22%
1.04
27.53%
net income per ebt
1
-
1
0%
1
0%
1.00
0.36%
1.00
0.24%
1
0.12%
0.99
1.48%
0.98
0.49%
net profit margin
-12.29
-
-17.07
38.89%
-24.37
42.82%
-46.14
89.29%
-4.52
90.20%
-2.47
45.27%
-0.86
65.31%
-0.38
55.77%
operating cash flow per share
-7.41
-
-11.37
53.31%
-4.67
58.90%
-4.00
14.46%
-1.89
52.73%
-1.21
36.01%
-0.76
37.25%
-0.35
53.84%
operating cycle
34.29
-
281.26
720.16%
424.82
51.04%
1.25K
194.62%
451.35
63.94%
625.03
38.48%
500.95
19.85%
446.27
10.91%
operating profit margin
-12.31
-
-17.11
39.05%
-24.07
40.67%
-44.96
86.75%
-4.15
90.78%
-2.32
43.98%
-0.74
67.99%
-0.27
63.87%
payables turnover
0.01
-
0.00
66.73%
0.05
2,295.84%
0.29
489.90%
2.99
946.02%
1.49
50.13%
4.91
229.27%
3.41
30.52%
pretax profit margin
-12.29
-
-17.07
38.89%
-24.37
42.82%
-46.30
89.98%
-4.53
90.22%
-2.47
45.34%
-0.87
64.78%
-0.39
55.55%
price fair value
-1.37
-
-0.76
44.78%
2.72
458.00%
12.75
369.54%
6.21
51.26%
2.43
60.87%
3.99
64.18%
-47.71
1,295.02%
receivables turnover
10.64
-
1.30
87.81%
0.86
33.79%
0.48
43.82%
2.93
507.33%
2.84
3.10%
3.58
25.88%
4.18
16.94%
return on assets
-0.39
-
-0.59
49.81%
-0.50
15.18%
-1.15
130.20%
-0.57
50.30%
-0.40
29.59%
-0.27
31.86%
-0.18
33.51%
return on capital employed
-0.43
-
-0.66
55.47%
-0.54
18.58%
-1.50
177.46%
-0.64
57.43%
-0.51
19.90%
-0.30
40.82%
-0.18
40.76%
return on equity
0.41
-
0.46
11.01%
-0.80
273.52%
-8.70
991.82%
-2.70
68.97%
-1.29
52.26%
-2.09
62.55%
9.18
538.19%
total debt to capitalization
-0.03
-
-0.05
59.16%
0.35
850.50%
0.80
130.87%
0.72
10.11%
0.48
33.31%
0.81
69.47%
1.04
27.25%

All numbers in USD (except ratios and percentages)